Literature DB >> 2206945

Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.

H Minagawa1, H Kobayashi, H Yoshida, M Teranishi, A Morikawa, S Abe, H Oshima, D I Mizuno.   

Abstract

Intratumoral induction of tumour necrosis factor (TNF) by administration of Bordetella pertussis vaccine (BPV) as compared with that by the agent OK-432 was investigated in mice. Two hours after such administration tumour tissues tested were resected from the mice, homogenised, and the TNF activities in the homogenate were assayed using a L-929 fibroblast assay. Intravenous injection of BPV into mice bearing the MM46 carcinoma resulted in a greater concentration of TNF in the tumour homogenate than in the serum. With OK-432, however, there was a greater concentration of TNF in the serum than in the tumour homogenates. A high level of intratumoral TNF induction by BPV was also observed in mice bearing Meth A fibrosarcoma or Lewis lung carcinoma. The therapeutic effect against the Meth A fibrosarcoma was in parallel with the intratumoral TNF activity. Intratumoral TNF activity is therefore believed to be a good index of therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206945      PMCID: PMC1971444          DOI: 10.1038/bjc.1990.300

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.

Authors:  M Satoh; Y Shimada; H Inagawa; H Minagawa; T Kajikawa; H Oshima; S Abe; M Yamazaki; D Mizuno
Journal:  Jpn J Cancer Res       Date:  1986-04

2.  Anti-tumour therapy by induction of endogenous tumour necrosis factor.

Authors:  M Kato; R Kakehi; G I Soma; T Gatanaga; D Mizuno
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.

Authors:  T Springer; G Galfré; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

5.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Endogenous production of TNF in mice long after BCG sensitization.

Authors:  M Satoh; H Inagawa; H Minagawa; T Kajikawa; H Oshima; S Abe; M Yamazaki; D Mizuno
Journal:  J Biol Response Mod       Date:  1986-04

7.  Endogenous production of TNF in mice with immune complex as a primer.

Authors:  M Satoh; H Inagawa; H Minagawa; T Kajikawa; H Oshima; S Abe; M Yamazaki; D Mizuno
Journal:  J Biol Response Mod       Date:  1986-04

8.  Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro.

Authors:  A Uchida; T Hoshino
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

9.  Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.

Authors:  T Gatanaga; K Takahashi; M Yamazaki; D Mizuno; S Abe
Journal:  Jpn J Cancer Res       Date:  1985-07

10.  [Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor].

Authors:  M Kato; D Ishiwata; R Kakehi; N Oshima; G Soma; D Mizuno
Journal:  Gan To Kagaku Ryoho       Date:  1987-07
View more
  1 in total

1.  Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.

Authors:  M Ohnishi; S Kimura; M Yamazaki; H Oshima; D I Mizuno; S Abe; H Yamaguchi
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.